Fed. Circ. Trims Galderma's Patent Win Over Oracea Generic
The Federal Circuit on Wednesday upheld a Delaware federal judge's ruling that Amneal infringed three patents covering Galderma's flagship rosacea drug Oracea, but said the generic-drug company didn't infringe two others....To view the full article, register now.
Already a subscriber? Click here to view full article